Crisp 3D scientific render of a chromatin loop structure, dark-field microscopy illumination, deep navy and gold tones, high-contrast macro focus, clinical laboratory aesthetic.
Crisp 3D scientific render of a chromatin loop structure, dark-field microscopy illumination, deep navy and gold tones, high-contrast macro focus, clinical laboratory aesthetic.
Review Technical Specifications
Explore Collaboration
Scientific Platform

The Alpha Omega 1N Logic platform is engineered to bypass the limitations of broad-spectrum oncology by isolating specific chromatin-level drivers. Below is an overview of our deterministic modeling and therapeutic design capabilities.

A patent-pending, non-viral gene-editing research platform engineered specifically for chromatin-level mechanistic modeling and therapeutic design in DIPG.

Core Capabilities

Mechanistically Grounded Architecture

Mechanistic Modeling. We utilize high-fidelity chromatin mapping to isolate the distinct epigenetic regulators of pediatric and adult high-grade gliomas. We model the molecular landscape to identify precise targets for therapeutic intervention.

Non-Viral Delivery

Chromatin Modeling

In Silico Pathways

Engineered to bypass traditional viral vector limitations. Our delivery designs prioritize genomic stability and high-fidelity target editing, minimizing insertional mutagenesis risks in complex CNS pathways.


Both pediatric high-grade gliomas (including DIPG) and adult pancreatic ductal adenocarcinoma present distinct epigenetic signatures that resist conventional chemotherapy. Our platform focuses strictly on the chromatin-level mechanics inherent to these indications, designing interventions that are structurally anchored in the specific biological data of the target cell.

Targeting the specific molecular landscape of pediatric high-grade gliomas to analyze epigenetic regulation and therapeutic response.

​

Our computational mapping for CNS oncology accelerates the translation from theoretical design to qualified clinical inquiry. This allows for rigorous screening of intervention pathways before laboratory wet-bench validation.

High-resolution digital render of molecular pathways in the central nervous system, cool laboratory light with subtle gold accents, macro framing, deep navy background.
High-resolution digital render of molecular pathways in the central nervous system, cool laboratory light with subtle gold accents, macro framing, deep navy background.
Targeted Oncology

The Chromatin Architecture of DIPG

Adult and Pediatric high-grade gliomas present distinct epigenetic drivers that resist broad-spectrum therapeutic approaches. Our platform isolates these chromatin-level mechanics to design highly localized, deterministic interventions.

By prioritizing non-viral delivery vectors, we preserve genomic stability while achieving high-fidelity target editing in complex central nervous system pathways.

Review Technical Specifications

Initiate Translational Alignment

We invite inquiries from qualified academic laboratories, pediatric neuro-oncology programs, and translational research organizations to validate and deploy our platform.